These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15632102)

  • 1. Pioglitazone improves insulin sensitivity through reduction in muscle lipid and redistribution of lipid into adipose tissue.
    Rasouli N; Raue U; Miles LM; Lu T; Di Gregorio GB; Elbein SC; Kern PA
    Am J Physiol Endocrinol Metab; 2005 May; 288(5):E930-4. PubMed ID: 15632102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation.
    Varma V; Yao-Borengasser A; Rasouli N; Bodles AM; Phanavanh B; Lee MJ; Starks T; Kern LM; Spencer HJ; McGehee RE; Fried SK; Kern PA
    J Clin Endocrinol Metab; 2007 Feb; 92(2):666-72. PubMed ID: 17090638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus.
    Teranishi T; Ohara T; Maeda K; Zenibayashi M; Kouyama K; Hirota Y; Kawamitsu H; Fujii M; Sugimura K; Kasuga M
    Metabolism; 2007 Oct; 56(10):1418-24. PubMed ID: 17884455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone.
    Di Gregorio GB; Yao-Borengasser A; Rasouli N; Varma V; Lu T; Miles LM; Ranganathan G; Peterson CA; McGehee RE; Kern PA
    Diabetes; 2005 Aug; 54(8):2305-13. PubMed ID: 16046295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone.
    Yao-Borengasser A; Varma V; Bodles AM; Rasouli N; Phanavanh B; Lee MJ; Starks T; Kern LM; Spencer HJ; Rashidi AA; McGehee RE; Fried SK; Kern PA
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2590-7. PubMed ID: 17595259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipin expression is attenuated in adipose tissue of insulin-resistant human subjects and increases with peroxisome proliferator-activated receptor gamma activation.
    Yao-Borengasser A; Rasouli N; Varma V; Miles LM; Phanavanh B; Starks TN; Phan J; Spencer HJ; McGehee RE; Reue K; Kern PA
    Diabetes; 2006 Oct; 55(10):2811-8. PubMed ID: 17003347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of metformin on peripheral insulin sensitivity and intracellular lipid contents in muscle and liver of overweight Japanese subjects.
    Tamura Y; Watada H; Sato F; Kumashiro N; Sakurai Y; Hirose T; Tanaka Y; Kawamori R
    Diabetes Obes Metab; 2008 Sep; 10(9):733-8. PubMed ID: 17941868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between visceral adiposity and intramyocellular lipid content in two rat models of insulin resistance.
    Korach-André M; Gao J; Gounarides JS; Deacon R; Islam A; Laurent D
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E106-16. PubMed ID: 15328072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients.
    Miyazaki Y; Mahankali A; Matsuda M; Mahankali S; Hardies J; Cusi K; Mandarino LJ; DeFronzo RA
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2784-91. PubMed ID: 12050251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pioglitazone-induced improvements in insulin sensitivity occur without concomitant changes in muscle mitochondrial function.
    Bajpeyi S; Pasarica M; Conley KE; Newcomer BR; Jubrias SA; Gamboa C; Murray K; Sereda O; Sparks LM; Smith SR
    Metabolism; 2017 Apr; 69():24-32. PubMed ID: 28285649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats.
    Sugiyama Y; Taketomi S; Shimura Y; Ikeda H; Fujita T
    Arzneimittelforschung; 1990 Mar; 40(3):263-7. PubMed ID: 2189419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone-induced increase in the stearoyl-CoA desaturation index and fat accumulation in rat muscles are not related to lipoprotein lipase activity.
    Ochiai M; Matsuo T
    J Oleo Sci; 2013; 62(9):745-54. PubMed ID: 24005019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose triglyceride lipase expression in human adipose tissue and muscle. Role in insulin resistance and response to training and pioglitazone.
    Yao-Borengasser A; Varma V; Coker RH; Ranganathan G; Phanavanh B; Rasouli N; Kern PA
    Metabolism; 2011 Jul; 60(7):1012-20. PubMed ID: 21129760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pioglitazone versus diet and exercise on metabolic health and fat distribution in upper body obesity.
    Shadid S; Jensen MD
    Diabetes Care; 2003 Nov; 26(11):3148-52. PubMed ID: 14578253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome.
    Ortega-González C; Luna S; Hernández L; Crespo G; Aguayo P; Arteaga-Troncoso G; Parra A
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1360-5. PubMed ID: 15598674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasonography modifications of visceral and subcutaneous adipose tissue after pioglitazone or glibenclamide therapy combined with rosuvastatin in type 2 diabetic patients not well controlled by metformin.
    Maffioli P; Fogari E; D'Angelo A; Perrone T; Derosa G
    Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1113-22. PubMed ID: 23524525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone added to conventional lipid-lowering treatment in familial combined hyperlipidaemia improves parameters of metabolic control: relation to liver, muscle and regional body fat content.
    Thomas EL; Potter E; Tosi I; Fitzpatrick J; Hamilton G; Amber V; Hughes R; North C; Holvoet P; Seed M; Betteridge DJ; Bell JD; Naoumova RP
    Atherosclerosis; 2007 Nov; 195(1):e181-90. PubMed ID: 17482623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of pioglitazone and metformin on insulin resistance and hormonal markers in patients with impaired glucose tolerance and early diabetes.
    Eguchi K; Tomizawa H; Ishikawa J; Hoshide S; Numao T; Fukuda T; Shimada K; Kario K
    Hypertens Res; 2007 Jan; 30(1):23-30. PubMed ID: 17460368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIOfix-study: effects of pioglitazone/metformin fixed combination in comparison with a combination of metformin with glimepiride on diabetic dyslipidemia.
    Pfützner A; Schöndorf T; Tschöpe D; Lobmann R; Merke J; Müller J; Lehmann U; Fuchs W; Forst T
    Diabetes Technol Ther; 2011 Jun; 13(6):637-43. PubMed ID: 21457065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved insulin sensitivity and adipose tissue dysregulation after short-term treatment with pioglitazone in non-diabetic, insulin-resistant subjects.
    Hammarstedt A; Sopasakis VR; Gogg S; Jansson PA; Smith U
    Diabetologia; 2005 Jan; 48(1):96-104. PubMed ID: 15624096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.